FSD Pharma Inc Price/Book
What is the Price/Book of FSD Pharma Inc?
The Price/Book of FSD Pharma Inc is 0.03
What is the definition of Price/Book?
Price to book ratio represents the ratio between a company’s stock value and the book value per share.
mrq (most recent quarter)
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book of companies in the Technology sector on NASDAQ compared to FSD Pharma Inc
What does FSD Pharma Inc do?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Companies with price/book similar to FSD Pharma Inc
- RM2 International S.A has Price/Book of 0.03
- Cypress Environmental Partners L.P has Price/Book of 0.03
- Ethernity Networks has Price/Book of 0.03
- Master Glory has Price/Book of 0.03
- Tencent has Price/Book of 0.03
- Seacoast Commerce Banc has Price/Book of 0.03
- FSD Pharma Inc has Price/Book of 0.03
- Leju Ltd has Price/Book of 0.03
- Datagroup Se has Price/Book of 0.03
- Celanese has Price/Book of 0.03
- Tubesolar Ag Inh O.N has Price/Book of 0.04
- e Athena has Price/Book of 0.04
- Sibanye Stillwater has Price/Book of 0.04